Project Grant Q184A080255

This federal Project Grant award of $731,258, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) grant program, supports a 12-week multicenter clinical trial to examine the efficacy of guanfacine extended release (GXR) versus placebo in reducing drinking severity in women with alcohol use disorder (AUD). The study aims to target alcohol craving and emotion regulation during stress as potential mechanisms. It will use a...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $537,587 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The University of Texas Southwestern Medical Center to conduct research on the metabolic consequences of liver inflammation on alcohol consumption and alcohol-associated liver disease (ALD). The key objectives are to identify the mechanisms by which the transcription factor IRF3 suppresses the expression and secretion of the metabolic regulator...

This $240,000 Project Grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program supports a four-year initiative to reduce underage drinking in Alachua County, Florida. The grant recipient, The Alachua County Health Promotion and Wellness Coalition, Inc., will implement a multi-pronged strategy to alter community norms, limit alcohol access, and...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $481,428 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Moses-Weitzman Health System, Inc. on September 20, 2024. The project, titled "Translating Research into Practice on Alcohol and Polysubstance Use Disorders by Educating the Interprofessional Primary Care Team," aims to improve the capacity of primary care providers in federally qualified health centers and other safety net settings to...

This $673,500 Project Grant from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism will fund Amygdala Neurosciences, Inc. to develop new, potent, selective, and reversible inhibitors of aldehyde dehydrogenase 2 (ALDH2) for the treatment of alcohol use disorder. The goal is to implement an innovative screening technology to discover novel compounds that reduce craving and alcohol consumption by selectively inhibiting ALDH2 in a reversible manner, avoiding...

This Project Grant award of $180,000 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will support the "Alcohol Attitude Adjustments in the Quaboag Hills - Our STOP ACT Program" over a four-year period from September 2024 to September 2028. The program will focus on reducing underage alcohol use and its impacts in the rural towns of Ware...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $399,048 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Rochester Institute of Technology (RIT) to examine behavioral and electrophysiological cue reactivity in young adult binge drinkers. The study will compare responses to uni- and multisensory alcohol and neutral cues that vary in degree of realistic appearance, and explore the effects of multisensory congruence on cue responses. The project...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $330,829 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Board of Regents of the University of Nebraska, University of Nebraska Medical Center (UNMC) Division. The grant, titled "Leveraging Alcohol Use Disorder Screening for Treatment in Routine Perioperative Care: ALLUSCARE", aims to leverage existing electronic health record-integrated alcohol screening tools to increase the provision of...

This $302,024 Project Grant was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the federal Alcohol Research Programs (CFDA 93.273) on September 14, 2023. The grant supports a research project by the Research Foundation of the City University of New York (RFCUNY) to assess the impacts of increased alcohol home delivery during the COVID-19 pandemic. The project aims to: 1) document compliance with age verification policies during alcohol home deliveries, 2)...

This three-year, $855,106 project grant from the National Institute on Alcohol Abuse and Alcoholism will fund research at the Reed Institute examining the impact of gender identification and group dynamics on alcohol-related decision making among emerging adults ages 18 to 25. The grant aims to recruit 260 participants identifying as cisgender or gender diverse to participate in automated simulations and interviews exploring how social contexts like group size and gender composition influence...